Literature DB >> 26836736

Prevalence and Cost of Office Visits Prior to Colonoscopy for Colon Cancer Screening.

Kevin R Riggs1, Jodi B Segal1, Eun Ji Shin2, Craig Evan Pollack1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26836736     DOI： 10.1001/jama.2015.15278

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Patient-Initiated Colonoscopy Scheduling Effectively Increases Colorectal Cancer Screening Adherence.

Authors:  Gautam Mankaney; Maged Rizk; Shashank Sarvepalli; Jeannie Bongorno; Ari Garber; Rocio Lopez; John McMichael; Carol A Burke
Journal:  Dig Dis Sci       Date:  2019-03-15       Impact factor: 3.199

2.  Open Access Colonoscopy for Colorectal Cancer Prevention: An Evaluation of Appropriateness and Quality.

Authors:  Nikhil Kapila; Harjinder Singh; Kiranmayee Kandragunta; Fernando J Castro
Journal:  Dig Dis Sci       Date:  2019-04-06       Impact factor: 3.199

3.  Open-access colonoscopy quality indicators and patient perception using split-dose bowel preparation.

Authors:  Nihita Manem; Katherine Donovan; David Miller; Michael Yodice; Katie Wang; Khadijat Balogun; Ghassan Kabbach; Paul Feustel; Micheal Tadros
Journal:  JGH Open       Date:  2021-03-22

4.  A National Survey of Adoption of the 2018 American Cancer Society Colorectal Cancer Screening Guideline in Primary Care.

Authors:  Andrew J Read; Akbar K Waljee; Sameer D Saini
Journal:  Clin Gastroenterol Hepatol       Date:  2020-08-29       Impact factor: 13.576

5.  Clinical care pathway program versus open-access system: a study on appropriateness, quality, and efficiency in the delivery of colonoscopy in the colorectal cancer.

Authors:  Giovanna Del Vecchio Blanco; Rami Dwairi; Mario Giannelli; Giampiero Palmieri; Vincenzo Formica; Ilaria Portarena; Enrico Grasso; Laura Di Iorio; Michela Benassi; Emilia Anna Giudice; Antonella Nardecchia; Piero Rossi; Mario Roselli; Giuseppe Sica; Giovanni Monteleone; Omero Alessandro Paoluzi
Journal:  Intern Emerg Med       Date:  2021-02-08       Impact factor: 3.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.